Abstract:Aβ 1–42 is the proteolytic cleavage product of cleavage of the amyloid precursor protein by β- and γ-secretases. The aggregation of Aβ 1–42 plays a causative role in the development of Alzheimer’s disease. To lock Aβ 1–42 in a homogenous state, we embedded the Aβ 1–42 sequence in an unstructured region of Bcl-x L . Both the N-terminus and the C-terminus of Aβ 1–42 were constrained in the disordered region, whereas the conjunction did not introduce any folding to Aβ 1–42 but maintained the sequence as a monomer in solution. With Bcl-x L -Aβ 42 , we developed an enzyme-linked immunosorbent assay to compare the affinity of compounds for monomeric Aβ 1–42 . Bcl-x L -Aβ 42 was coated on a microplate and this was followed by incubation with different concentrations of compounds. Compounds binding to Leu17-Val24 of Aβ 1–42 inhibited the interaction between Bcl-x L -Aβ 42 and antibody 4G8. The method can not only reproduce the activities of the reported Aβ 1–42 inhibitors such as dopamine, tannin, and morin but can also differentiate decoy compounds that do not bind to Aβ 1–42 . Remarkably, using this method, we discovered a new inhibitor that binds to monomeric Aβ 1–42 and inhibits Aβ 1–42 fibril formation. As the structure of Bcl-x L -Aβ 42 monomer is stable in solution, the assay could be adapted for high-throughput screening with a series of antibodies that bind the different epitopes of Aβ 1–42 . In addition, the monomeric form of the Aβ 1–42 sequence in Bcl-x L -Aβ 42 would also facilitate the identification of Aβ 1–42 binding partners by coimmunoprecipitation, cocrystallization, surface plasmon resonance technology, or the assay as described here. Figure Schematic diagram of an enzyme-linked immunosorbent assay to compare the affinity of chemical compounds for β-amyloid peptide in monomer

Exploring the Binding Mechanism of Thioflavin-T to the Β-Amyloid Peptide by Blind Docking Method

Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.

Inhibitor discovery targeting the intermediate structure of β-amyloid peptide on the conformational transition pathway: Implications in the aggregation mechanism of β-amyloid peptide

In Silico Study of Recognition Between Aβ40 and Aβ40 Fibril Surfaces: an N-Terminal Helical Recognition Motif and Its Implications for Inhibitor Design

Energy Landscapes of the Monomer and Dimer of the Alzheimer’s Peptide Aβ(1–28)

Amyloid β (1–42) Folding Multiplicity and Single-Molecule Binding Behavior Studied with STM

An enzyme-linked immunosorbent assay to compare the affinity of chemical compounds for β-amyloid peptide as a monomer

An Enzyme-Linked Immunosorbent Assay To Compare The Affinity Of Chemical Compounds For Beta-Amyloid Peptide As A Monomer

Biophysical Studies of Amyloid-Binding Fluorophores to Tau AD Core Fibrils Formed without Cofactors

Binding Research on Flavone Derivatives As Probes for Beta-Amyloid Plaques

Membrane Binding and Pore Formation by a Cytotoxic Fragment of Amyloid β Peptide.

Thioflavin T fluoresces as excimer in highly concentrated aqueous solutions and as monomer being incorporated in amyloid fibrils

A Theoretical Study On The Molecular Determinants Of The Affibody Protein Z(A Beta 3) Bound To An Amyloid Beta Peptide

Specific Binding of Alzheimer's Aβ Peptides to Extracellular Vesicles

Molecular Integrative Analysis of the Inhibitory Effects of Dipeptides on Amyloid β Peptide 1–42 Polymerization

Investigation of the Aggregation Process of Amyloid-Β-(16-22) Peptides and the Dissolution of Intermediate Aggregates.

In Silico Study on the Effect of F19T Mutation on Amyloid-Beta Peptide (10-35).

Binding of a Pyrene-Based Fluorescent Amyloid Ligand to Transthyretin: A Combined Crystallographic and Molecular Dynamics Study

Kinetics of Inhibition of Β-Amyloid Aggregation by Transthyretin

Structural Insights into the Co-Aggregation of Aβ and Tau Amyloid Core Peptides: Revealing Potential Pathological Heterooligomers by Simulations.

The Binding of Resveratrol to Monomer and Fibril Amyloid Beta